BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 18097341)

  • 21. Long-term macrolide treatment of chronic inflammatory airway diseases: risks, benefits and future developments.
    Cameron EJ; McSharry C; Chaudhuri R; Farrow S; Thomson NC
    Clin Exp Allergy; 2012 Sep; 42(9):1302-12. PubMed ID: 22925316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-inflammatory capabilities of macrolides.
    Zalewska-Kaszubska J; Górska D
    Pharmacol Res; 2001 Dec; 44(6):451-4. PubMed ID: 11735349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macrolides as immunomodulatory medications for the therapy of chronic lung diseases.
    López-Boado YS; Rubin BK
    Curr Opin Pharmacol; 2008 Jun; 8(3):286-91. PubMed ID: 18339582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concurrent use of corticosteroids and antimicrobial drugs in the treatment of infectious diseases in large animals.
    Jenkins WL
    J Am Vet Med Assoc; 1984 Nov; 185(10):1145-9. PubMed ID: 6392244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concurrent use of corticosteroids and antimicrobial drugs in the treatment of infectious diseases in small animals.
    Ford RB
    J Am Vet Med Assoc; 1984 Nov; 185(10):1142-4. PubMed ID: 6392243
    [No Abstract]   [Full Text] [Related]  

  • 26. [New 1,2-diazine derivatives with antimicrobial and anti-inflammatory action].
    Ungureanu M; Dorneanu M; Stefănescu E; Pavelescu M; Radu C; Petrovanu M
    Rev Med Chir Soc Med Nat Iasi; 1984; 88(4):709-11. PubMed ID: 6537642
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunomodulatory properties of antibiotics.
    Tauber SC; Nau R
    Curr Mol Pharmacol; 2008 Jan; 1(1):68-79. PubMed ID: 20021425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune modulatory effects of statins.
    Zeiser R
    Immunology; 2018 May; 154(1):69-75. PubMed ID: 29392731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bovine colostrum--therapeutic synergism involving immunomodulation, nutritional supplementation and antibacterial action?
    Waaga-Gasser AM
    Int J Clin Pharmacol Ther; 2007 Apr; 45(4):191-2. PubMed ID: 17474537
    [No Abstract]   [Full Text] [Related]  

  • 30. Macrolide therapy in chronic inflammatory diseases.
    Kwiatkowska B; Maślińska M
    Mediators Inflamm; 2012; 2012():636157. PubMed ID: 22969171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Host defense peptides as immunomodulators: The other side of the coin.
    Martell EM; González-Garcia M; Ständker L; Otero-González AJ
    Peptides; 2021 Dec; 146():170644. PubMed ID: 34464592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunomodulatory properties of macrolides].
    Targowski T; Jahnz-Rózyk K
    Pol Merkur Lekarski; 2008 Nov; 25(149):408-11. PubMed ID: 19177776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macrolide antibiotics, bacterial populations and inflammatory airway disease.
    Swords WE; Rubin BK
    Neth J Med; 2003 Jul; 61(7):242-8. PubMed ID: 14567521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial Effects of Antipyretics.
    Zimmermann P; Curtis N
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Solanum muricatum Ait. inhibits inflammation and cancer by modulating the immune system.
    Shathish K; Guruvayoorappan C
    J Cancer Res Ther; 2014; 10(3):623-30. PubMed ID: 25313750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial and immunomodulatory attributes of statins: relevance in solid-organ transplant recipients.
    Sun HY; Singh N
    Clin Infect Dis; 2009 Mar; 48(6):745-55. PubMed ID: 19193110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Boswellic acids in chronic inflammatory diseases.
    Ammon HP
    Planta Med; 2006 Oct; 72(12):1100-16. PubMed ID: 17024588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of IBD: where we are and where we are going.
    Bernstein CN
    Am J Gastroenterol; 2015 Jan; 110(1):114-26. PubMed ID: 25488896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial peptides.
    Izadpanah A; Gallo RL
    J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):381-90; quiz 391-2. PubMed ID: 15761415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimized nonclinical safety assessment strategies supporting clinical development of therapeutic monoclonal antibodies targeting inflammatory diseases.
    Brennan FR; Cauvin A; Tibbitts J; Wolfreys A
    Drug Dev Res; 2014 May; 75(3):115-61. PubMed ID: 24782266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.